Navigation Links
Heptares Augments Business Development Capabilities in Japan and Other Asian Territories
Date:5/24/2013

WELWYN GARDEN CITY, England and BOSTON, May 24, 2013 /PRNewswire/ --

Heptares Therapeutics, the leading GPCR drug discovery and development company, is pleased to announce that it has engaged Mr Akira Usui as a Consultant to augment the Company's business development capabilities in Japan and other Asian territories.

Mr Usui has more than 15 years of experience in business development, licensing and alliance management in the pharmaceutical industry including senior roles at Perlegen Sciences, Inc., Roche Pharma (Japan), Nippon Roche and Tanabe Seiyaku Co. Ltd. Mr Usui is President of Ray Life Sciences Inc., which he established in 2007 to provide business and corporate development consulting services to pharma and biotech companies, universities and venture capital firms with a specific focus on the Japanese market.

Barry Kenny , Heptares' Chief Business Officer, said: "Akira has an exceptional depth of experience in business development and an impressive track record in implementing agreements across multiple international territories. In addition to our existing partnership with Takeda, we are developing significant interest from pharmaceutical companies in Japan in what Heptares' technology can offer. We look forward to working with Akira, who will provide additional support in this region, to manage and advance these multiple new business opportunities for our unique GPCR-focused drug discovery and development capabilities."  

Mr Usui added: "Heptares has established itself as the leader in GPCR-focused drug discovery and has achieved significant milestones both with its partners and in building its own pipeline of drug candidates. Its platform and approach has the potential to unlock the GPCR space to drug discovery and enable the development of new and better targeted medicines for diseases with few effective treatments. I am delighted to work with the Company as it seeks to increase its business development activities in Japan and Asia."

 

About Heptares Therapeutics

Heptares creates new medicines targeting clinically important, yet historically challenging, GPCRs (G protein-coupled receptors), a superfamily of drug receptors linked to a wide range of human diseases. Leveraging our advanced structure-based drug design technology platform, we have built an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including Alzheimer's disease, Parkinson's disease, schizophrenia, migraine and diabetes. Our pharmaceutical partners include Shire, Cubist, Takeda, MorphoSys, AstraZeneca and MedImmune, and we are backed by MVM Life Science Partners, Clarus Ventures, Novartis Venture Fund and Takeda Ventures. To learn more about Heptares, please visit http://www.heptares.com.


'/>"/>
SOURCE Heptares Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Heptares and UK Medical Research Council Extend GPCR Collaboration
2. Heptares to Present at 5th CNS Partnering and Deal-Making Conference (13-14 SEPTEMBER)
3. Heptares to Present at the 6th Annual European Life Sciences CEO Forum (5-6 March)
4. Heptares to Present at Boston Biotech BD and Future Leaders in the Biotech Industry Conferences
5. Generex Augments Antigen Express Scientific Advisory Board
6. Lower Operating Expense Augments Digital X-rays Uptake Across Industries, Finds Frost & Sullivan
7. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
8. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
9. Nominations Open for San Francisco Business Times Health Care Heroes Awards
10. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association
11. Amendia, Inc. and Medline Industries, Inc. Announce Investment and Strategic Business Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... 2017  South Korean-based healthcare product Development Company I.M. ... on Kickstarter. The device will educate the user about ... better efficiency compared to the dated and pricey CPR ... efficacy of the compression for a more informed CPR ... to raise $5,000. ...
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
Breaking Medicine News(10 mins):